Development and Immunogenicity of a Brazilian Glycoconjugate vaccine against Meningococcal W in a Pilot Scale
- 13 September 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Glycoconjugate Journal
- Vol. 38 (5), 539-549
- https://doi.org/10.1007/s10719-021-10016-w
Abstract
Recent changes in the epidemiology of meningococcal have been reported and meningococcal group W (MenW) has become the third most prevalent group isolated in Brazil in the last 10 years. In this study we have developed a conjugate vaccine for MenW using a modified reductive amination conjugation method through a covalent linkage between periodate-oxidized MenW non-O-acetylated polysaccharide and hydrazide-activated monomeric tetanus toxoid. Process control of bulks was done by physicochemical analysis including polysaccharide and protein quantification, high performance liquid chromatography – size exclusion chromatography, capillary electrophoresis, and hydrogen nuclear magnetic resonance. Conjugate bulks were best produced with concentration of polysaccharide twice as high as protein, at room temperature, and pH approximately 6.0. A scaled-up bulk (100 mg scale) was formulated and inoculated intramuscularly in mice in a dose–response study (0.1, 0.5, 1.0 and 10.0 µg of polysaccharide/dose). The immunogenicity of conjugate bulks was determined by serum bactericidal assay and ELISA assays of serum from immunized mice. ELISA and SBA titers revealed high titers of IgG and demonstrated the functionality of the antibodies produced in all doses studied 15 days after the third dose. However, significant differences were observed among them by ELISA. In conclusion, this study established the best conditions to produce MenW conjugate bulks and showed the efficacy of the obtained conjugate bulk in induce a good immune response in mice. Further experiments will need to be done to scale up the conjugation reaction and then allow the use of this conjugate in clinical trials.Keywords
This publication has 47 references indexed in Scilit:
- The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscapeEpidemiology and Infection, 2012
- Development of a group A meningococcal conjugate vaccine,MenAfriVacTMHuman Vaccines & Immunotherapeutics, 2012
- Insights into chemokine receptorsNature Reviews Drug Discovery, 2010
- Meningococcal group A, C, Y and W-135 conjugate vaccineNature Reviews Drug Discovery, 2010
- Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in BrazilJournal of Infection, 2010
- Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccinesArchives of Disease in Childhood, 2007
- Analysis of Human Serum Immunoglobulin G againstO-Acetyl-Positive andO-Acetyl-Negative Serogroup W135 Meningococcal Capsular PolysaccharideClinical and Vaccine Immunology, 2005
- Preparation and Characterization of Group A Meningococcal Capsular Polysaccharide Conjugates and Evaluation of Their Immunogenicity in MiceInfection and Immunity, 2003
- Standardisation and Validation of Serological Assays for the Evaluation of Immune Responses to Neisseria meningitidis Serogroup A and C VaccinesBiologicals, 2000
- Quantitive estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid methodBiochimica et Biophysica Acta, 1957